Treatment for latent TB in correctional facilities: A challenge for TB elimination

American Journal of Preventive Medicine

Volumn 24, Issue 3, 2003, Pages 249-253

  Lobato, Mark N ^a,b   Leary, Linda S ^a   Simone, Patricia M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ISONIAZID;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LIVER TOXICITY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRISON; TUBERCULIN TEST; UNITED STATES;

EID: 0037378153     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-3797(02)00583-4     Document Type: Article

References (29)

1. Tuberculosis transmission in a state correctional institution - California, 1990-1991. MMWR Morb Mort Wkly Rep. 41:1992;927-929.
2. Valway S.E., Greifinger R.B., Papania M., et al. Multidrug-resistant tuberculosis in the New York State prison system, 1990-1991. J Infect Dis. 170:1994;151-156.
3. MacIntyre C.R., Kendig N., Kummer L., Birago S., Graham N.M.H., Plant A.J. Unrecognized transmission of tuberculosis in prisons. Eur J Epidemiol. 15:1999;705-709.
4. MacIntyre C.R., Kendig N., Kummer L., Birago S., Graham N.M.H. Impact of tuberculosis control measures and crowding on the incidence of tuberculous infection in Maryland prisons. Clin Infect Dis. 24:1997;1060-1070.
5. Bellin E.Y., Fletcher D.D., Safyer S.M. Association of tuberculosis infection with increased time in or admission to the New York City jail system. JAMA. 269:1993;2228-2231.
6. Stead W.W. Undetected tuberculosis in prison - source of infection for community at large. JAMA. 240:1978;2544-2547.
7. Pelletier A.R., DiFerdinando G.T., Greenberg A.J., et al. Tuberculosis in a correctional facility. Arch Intern Med. 153:1993;2692-2695.
8. Jones T.F., Craig A.S., Valway S.E., Woodley C.L., Schaffner W. Transmission of tuberculosis in a jail. Ann Intern Med. 131:1999;557-563.
9. Bock N.N., Reeves M., LaMarre M., DeVoe B. Tuberculosis case detection in a state prison system. Public Health Reports. 113:1998;359-364.
10. Cone J.E., Harrison R., Katz E., Chan J., Dewsnup D., Osorio A.M. Tuberculosis transmission to prison employees during an outbreak among prisoners at two California prisons. J Healthcare Safety Compliance Infect Control. 4:2000;75-79.
11. Tuberculosis elimination revisited obstacles, opportunities, and a renewed commitment. Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mort Wkly Rep. 48:1999;1-13.
12. Hutton M.D., Cauthen G.M., Bloch A.B. Results of a 29-state survey of tuberculosis in nursing homes and correctional facilities. Public Health Rep. 108:1993;305-314.
13. Braun M.M., Truman B.I., Maguire B., et al. Increasing incidence of tuberculosis in a prison inmate population. JAMA. 261:1989;393-397.
14. Hammett T.M., Gaiter J.L., Crawford C. Reaching seriously at-risk populations health interventions in criminal justice settings. Health Educ Behav. 25:1998;99-120. 25.
15. Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Morb Mort Wkly Rep 2000;49:2.
16. Prevention and control of tuberculosis in correctional facilities. MMWR Morb Mort Wkly Rep. 45:1996;6-14.
17. Bandyopadhyay T., Murray H., Metersky M.L. Cost-effectiveness of tuberculosis prophylaxis after release from short-term correctional facilities. Chest. 121:2000;1771-1775.
18. Conklin T.J., Lincoln T., Flanigan T.P. A public health model to connect correctional health care with communities. Am J Public Health. 88:1998;1249-1250.
19. Wilcock K, Hammett TM, Parent DG. Controlling tuberculosis in community corrections. Washington, DC: National Institute of Justice, Research in Action, May 1995.
20. Bucher H.C., Griffith L.E., Guyatt G.H., et al. Isoniazid prophylaxis for tuberculosis in HIV infection a meta-analysis of randomized controlled trials. AIDS. 13:1999;501-507.
21. Markowitz N., Hansen N.I., Hopewell P.C., et al. Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group. Ann Intern Med. 126:1997;123-132.
22. Hammett TM, Harmon P, Maruschak LM. 1996-1997 Update: HIV/AIDS, STDs, and TB in correctional facilities. Washington, DC: National Institute of Justice, Research in Action, July 1999.
23. Centers for Disease Control and Prevention. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: Principles of therapy and revised recommendations. MMWR Morb Mort Wkly Rep 1998;47:18-22.
24. Tuberculosis Program management reports. 1996;Centers for Disease Control and Prevention, Atlanta, GA.
25. Peterson Tulsky J., Castle White M., Dawson C., Hoynes T.M., Goldenson J., Schecter G. Screening for tuberculosis in jail and clinic follow-up after release. Am J Public Health. 88:1998;223-226.
26. Bock N., Rogers T., Tapia J.R., Herron G.D., DeVoe B., Geiter L.J. Acceptability of short-course rifampin and pyrazinamide treatment of latent tuberculosis infection among jail inmates. Chest. 119:2001;833-837.
27. Update fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC Recommendations - United States, 2001. MMWR Morb Mort Wkly Rep. 50:2001;733-735.
28. White M.C., Tulsky J.P., Reilly P., McIntosh H.W., Hoynes T.M., Goldenson J. A clinical trial of a financial incentive to go to the tuberculosis clinic for isoniazid after release from jail. Int J Tuberc Lung Dis. 2:1998;506-512.
29. Geiter L. Ending neglect: the elimination of tuberculosis in the United States. 2000;Institute of Medicine/National Academy Press, Washington, DC.